12 Questions to Ask Before Booking a Stem Cell Clinic

Stem cell clinics often use hopeful language, polished testimonials, and medical-sounding terms. That can make it hard to tell what is established, what is experimental, and what is simply unclear.

This guide does not tell anyone whether to get a stem cell treatment. It shows how to investigate a clinic before booking, so the questions are specific enough to reveal what is actually being offered.

Stem cell products are not all the same. A bone marrow transplant for certain blood disorders is very different from an injection marketed for joint pain, neuropathy, hair loss, “anti-aging,” or general wellness. The details matter.

This article is for consumer education only. It is not medical advice, legal advice, or a substitute for care from a licensed clinician who knows the full medical history.

Start by asking what the clinic is actually offering

A credible clinic should be able to describe the product in plain language and in medical detail. If the answer stays vague, that is useful information.

The word “stem cell” can refer to many different products, including blood-forming stem cells, bone marrow-derived cells, fat-derived cells, amniotic or umbilical cord tissue products, exosomes, platelet-rich plasma mixed with cells, or other processed materials. Some are living cells. Some may not contain stem cells in a meaningful amount. Some products promoted as stem cell treatments may not be stem cell products at all.

Before discussing price, scheduling, or expected results, ask for written answers to the questions below.

The 12 questions to ask before booking

1. What is the exact cell product being used?

Ask for the exact name of the product, not a general term like “regenerative cells” or “young cells.”

The clinic should identify whether the product is:

• Bone marrow aspirate concentrate

• Adipose-derived cells from fat tissue

• Umbilical cord blood or cord tissue product

• Amniotic tissue product

• Exosomes or extracellular vesicles

• Platelet-rich plasma combined with another product

• Another defined product

  
  

Also ask whether the product contains live cells, and whether the clinic can document that. If the product is marketed as “stem cells,” ask what type of stem cells are present and how the clinic verifies that claim.

A clear answer sounds specific. A vague answer often leans on phrases like “natural healing,” “cellular therapy,” or “regenerative solution” without stating the product.

2. What is the source of the cells or tissue?

Source matters for safety, regulation, and expectations.

Ask whether the cells come from the patient’s own body, from a donor, from birth tissue, or from a commercial supplier. If donor tissue is involved, ask how donors are screened and tested. If the tissue comes from umbilical cord or amniotic sources, ask whether the product is cord blood, cord tissue, Wharton’s jelly, amniotic membrane, amniotic fluid, or another material.

Do not accept “ethically sourced” as the full answer. That may be reassuring language, but it does not explain donor screening, infectious disease testing, chain of custody, or product identity.

3. How is the product processed?

Processing can change the nature of a product. Ask what happens between collection and injection or infusion.

For example, the clinic may centrifuge bone marrow, use enzymes on fat tissue, thaw a donor product, filter cells, culture-expand cells, or combine products. Each step can affect cell counts, contamination risk, and regulatory status.

Ask these questions:

• Is the product processed on-site or by an outside lab?

• Is it used the same day or stored?

• Is it frozen and thawed?

• Are enzymes, culture expansion, or additives used?

• What sterility testing is done?

• Who handles the product?

  
  

If the clinic says processing is “minimal,” ask what that means in writing. In the United States, regulatory terms have specific meaning. Marketing use of the word does not settle the question.

4. What viability and quality checks are performed?

If a treatment relies on living cells, the clinic should be able to describe how it checks cell viability and quality.

Cell viability means the percentage of cells that are alive at the time they are used. A product may contain cellular material but few living cells. The clinic should explain whether viability is measured for the specific product, the lot, or the individual patient sample.

Ask whether the clinic measures:

• Total nucleated cell count

• Cell viability

• Sterility or microbial contamination

• Endotoxin, when relevant

• Product identity or markers, when claimed

  
  

A clinic may not perform every test for every product, but it should be transparent about what it does and does not measure.

5. What dose will be given?

Dose is a basic medical detail. Ask how much product will be administered and how the clinic defines the dose.

Depending on the product, dose might involve volume, total cell count, viable cell count, concentration, number of injections, or another measurement. A clinic should not treat dosing as an afterthought.

Ask:

• What dose is planned?

• Is the dose based on body weight, diagnosis, imaging, or a fixed package?

• How many treatment sessions are included?

• What evidence supports that dose for the condition being treated?

• Will the dose be documented in the medical record?

  
  

Be cautious when a clinic promises that “more cells are better.” Biology is rarely that simple, and higher amounts do not automatically mean better outcomes or lower risk.

6. What route of administration will be used?

How a product enters the body affects risk. Ask whether the treatment is injected into a joint, tendon, spine area, muscle, bloodstream, nasal passage, skin, scalp, or another site.

Also ask who performs the procedure and whether imaging guidance is used when needed. For example, an injection into a joint or near the spine raises different safety questions than a superficial skin procedure.

Get clear answers on:

• The exact injection or infusion site

• Whether ultrasound, fluoroscopy, or another guide is used

• Whether sedation is involved

• What complications are possible for that route

• What emergency support is available

  
  

Terms like “systemic delivery” or “targeted delivery” sound impressive, but the practical question is simple: where does the product go, and how is the procedure done?

7. What are the physician’s credentials and role?

Ask who evaluates the patient, who recommends the treatment, and who performs it.

The answer should include licensure, board certification, specialty training, and experience with the specific procedure. A physician’s credentials should match the condition and the method. For example, a joint injection, eye treatment, neurologic condition, or spinal procedure each calls for different expertise.

Ask:

• Is a licensed physician involved in the diagnosis and treatment plan?

• What is the physician’s specialty?

• Who performs the procedure?

• Who manages complications after hours?

• Does the clinic coordinate with the patient’s regular doctor?

  
  

If most of the discussion happens with a salesperson or “patient coordinator,” ask for a medical consultation before making any decision.

8. What is the regulatory status of the treatment?

In the United States, the Food and Drug Administration regulates many human cell and tissue products. Some products fall into categories that require FDA review and approval before marketing. Others may meet criteria that allow a different regulatory pathway.

Ask the clinic to state the treatment’s regulatory status in writing.

Useful questions include:

• Is this product FDA-approved for this condition?

• If not, is it being used under an Investigational New Drug application?

• Is it part of an Institutional Review Board reviewed clinical trial?

• Is the product described as an HCT/P under FDA rules?

• If the clinic claims an exception applies, what is the basis?

  
  

“FDA registered” is not the same as FDA-approved. A facility registration does not prove that a treatment is approved, effective, or appropriate for a condition.

9. What published evidence supports this use?

Ask for peer-reviewed studies on the same product, same condition, same route of administration, and similar dose.

This matters because evidence from one setting does not automatically transfer to another. A study on blood-forming stem cells for a blood disorder does not prove that a fat-derived product helps knee arthritis. A small uncontrolled case series does not carry the same weight as a randomized controlled trial.

Ask the clinic to provide:

• Peer-reviewed journal articles

• Details on the product used in the studies

• The outcomes measured

• The length of follow-up

• Known limitations and unanswered questions

  
  

Testimonials can be sincere and still unreliable as proof. People may improve because of natural recovery, placebo effects, physical therapy, other treatments, lifestyle changes, or normal symptom ups and downs. People with poor results may be less likely to appear in marketing. Testimonials also rarely track all patients in a consistent way.

A good question is: What happened to everyone treated, not just the people featured in success stories?

10. Is there a registered clinical trial?

If the clinic describes the treatment as research, ask for the trial registration number.

In the United States, many clinical trials are listed on ClinicalTrials.gov. Registration does not prove a study is high quality, and it does not mean the treatment works. It helps consumers verify that a study exists and review its goals, eligibility criteria, locations, sponsor, and outcomes.

Ask:

• Is this treatment part of a registered clinical trial?

• What is the registration number?

• Who is the sponsor?

• Is there an Institutional Review Board?

• Are participants charged, and if so, for what?

• What outcomes will be measured?

• Will results be reported?

  
  

Be cautious if a clinic calls routine paid care a “study” but cannot provide registration details, consent documents, or a clear research protocol.

11. How are adverse events reported and follow-up handled?

Every medical procedure has possible risks. A responsible clinic should explain them directly, not dismiss them.

Ask how the clinic tracks and reports adverse events. Ask what counts as an adverse event, who reviews it, and whether serious events are reported to regulators, sponsors, review boards, or product manufacturers when required.

Also ask about follow-up:

• How often will follow-up happen?

• Will it be in person, online, or by phone?

• What symptoms require urgent care?

• Who answers questions after hours?

• Will imaging, labs, or function scores be repeated?

• How long does the clinic track outcomes?

  
  

Follow-up should not consist only of asking for a positive review. It should include safety checks, outcome tracking, and clear instructions for complications.

12. What are the full costs and what does informed consent include?

Stem cell treatments marketed directly to consumers can be expensive, and insurance may not cover them. Ask for a written estimate before paying a deposit.

The estimate should include the consultation, lab work, imaging, product fee, facility fee, procedure fee, anesthesia or sedation, follow-up visits, medications, repeat treatments, and possible costs if complications occur.

Then review the informed consent. A strong consent process gives time to ask questions and does not pressure anyone to sign immediately.

Look for clear explanations of:

• The product and source

• The procedure steps

• Expected benefits and limits

• Common and serious risks

• Alternatives, including no treatment

• Regulatory status

• Costs and refund policies

• Privacy and data use

• Follow-up responsibilities

  
  

If the consent form says the treatment is experimental, read that word carefully. Experimental does not always mean wrong, but it does mean the benefits and risks may be less certain.

How to judge the answers you receive

The goal is not to memorize regulatory terms. The goal is to see whether the clinic can answer basic questions clearly, consistently, and in writing.

A clinic that is operating responsibly should welcome careful questions. It should give documents, not just reassurance. It should explain uncertainty, not promise guaranteed repair.

Watch for warning signs such as:

• Claims that one product treats many unrelated conditions

• Pressure to book quickly or pay the same day

• Discounts tied to immediate payment

• No clear product name or source

• No clear physician involvement

• Heavy reliance on testimonials

• Claims of being “FDA compliant” without explaining regulatory status

• Promises of no risk

• Refusal to share consent forms before payment

  
  

Keep records of calls, emails, consent forms, lot numbers, receipts, and follow-up instructions. If a procedure happens, ask for documentation of the product used, dose, route, and date.

The takeaway before booking

A stem cell clinic evaluation should come down to specifics. What is the product? Where did it come from? How was it processed? Is it alive? What dose is used? How is it given? Who is responsible for care? What is the regulatory status? What evidence supports this exact use? Is there a registered trial? How are problems tracked? What will it cost, and what does the consent form really say?

Testimonials can raise questions, but they cannot answer those questions. Clear documentation can.

Before booking, gather the clinic’s written answers and review them with a qualified, independent medical professional who is not selling the treatment. That extra step can make the difference between an emotional decision and an informed one.